Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.

Guo J, Canaff L, Rajadurai CV, Fils-Aimé N, Tian J, Dai M, Korah J, Villatoro M, Park M, Ali S, Lebrun JJ.

Breast Cancer Res. 2014 Dec 13;16(6):476. doi: 10.1186/s13058-014-0476-9.

2.

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.

Sieuwerts AM, Lyng MB, Meijer-van Gelder ME, de Weerd V, Sweep FC, Foekens JA, Span PN, Martens JW, Ditzel HJ.

Mol Oncol. 2014 Dec;8(8):1679-89. doi: 10.1016/j.molonc.2014.07.003. Epub 2014 Jul 10.

3.

p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells.

Cunningham-Edmondson AC, Hanks SK.

Breast Cancer (Dove Med Press). 2009 Dec 7;1:39-52. eCollection 2009.

4.

NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Wallez Y, Mace PD, Pasquale EB, Riedl SJ.

Genes Cancer. 2012 May;3(5-6):382-93. doi: 10.1177/1947601912460050.

5.

Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland.

Datta K, Hyduke DR, Suman S, Moon BH, Johnson MD, Fornace AJ Jr.

Radiat Oncol. 2012 Dec 5;7:205. doi: 10.1186/1748-717X-7-205.

6.

A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.

Tu L, De Man FS, Girerd B, Huertas A, Chaumais MC, Lecerf F, François C, Perros F, Dorfmüller P, Fadel E, Montani D, Eddahibi S, Humbert M, Guignabert C.

Am J Respir Crit Care Med. 2012 Oct 1;186(7):666-76. doi: 10.1164/rccm.201202-0309OC. Epub 2012 Jul 12.

8.

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study.

Sieuwerts AM, Ansems M, Look MP, Span PN, de Weerd V, van Galen A, Foekens JA, Adema GJ, Martens JW.

Breast Cancer Res. 2010;12(6):R103. doi: 10.1186/bcr2786. Epub 2010 Dec 1.

9.

BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling.

Schuh NR, Guerrero MS, Schrecengost RS, Bouton AH.

J Biol Chem. 2010 Jan 22;285(4):2309-17. doi: 10.1074/jbc.M109.046631. Epub 2009 Nov 23.

10.

CAS proteins in normal and pathological cell growth control.

Tikhmyanova N, Little JL, Golemis EA.

Cell Mol Life Sci. 2010 Apr;67(7):1025-48. doi: 10.1007/s00018-009-0213-1. Epub 2009 Nov 25. Review.

11.

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.

van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, Brinkman A, den Dekker AT, Leroy IM, van Ijcken WF, Sleijfer S, Foekens JA, Dorssers LC.

Br J Cancer. 2009 Dec 1;101(11):1824-32. doi: 10.1038/sj.bjc.6605423. Epub 2009 Nov 10.

12.

Supplemental Content

Support Center